These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 23919928)

  • 1. Adverse drug reactions and off-label and unlicensed medicines in children: a prospective cohort study of unplanned admissions to a paediatric hospital.
    Bellis JR; Kirkham JJ; Nunn AJ; Pirmohamed M
    Br J Clin Pharmacol; 2014 Mar; 77(3):545-53. PubMed ID: 23919928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse drug reactions and off-label and unlicensed medicines in children: a nested case-control study of inpatients in a pediatric hospital.
    Bellis JR; Kirkham JJ; Thiesen S; Conroy EJ; Bracken LE; Mannix HL; Bird KA; Duncan JC; Peak M; Turner MA; Smyth RL; Nunn AJ; Pirmohamed M
    BMC Med; 2013 Nov; 11():238. PubMed ID: 24229060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients.
    Neubert A; Dormann H; Weiss J; Egger T; Criegee-Rieck M; Rascher W; Brune K; Hinz B
    Drug Saf; 2004; 27(13):1059-67. PubMed ID: 15471510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study.
    Turner S; Nunn AJ; Fielding K; Choonara I
    Acta Paediatr; 1999 Sep; 88(9):965-8. PubMed ID: 10519338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is off-label use a risk factor for adverse drug reactions in pediatric patients? A prospective study in an Indian tertiary care hospital.
    Saiyed MM; Lalwani T; Rana D
    Int J Risk Saf Med; 2015; 27(1):45-53. PubMed ID: 25766066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Off-label and unlicensed utilisation of medicines in a French paediatric hospital.
    Joret-Descout P; Prot-Labarthe S; Brion F; Bataille J; Hartmann JF; Bourdon O
    Int J Clin Pharm; 2015 Dec; 37(6):1222-7. PubMed ID: 26394784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
    Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
    Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescribing of medicines in the Danish paediatric population outwith the licensed age group: characteristics of adverse drug reactions.
    Aagaard L; Hansen EH
    Br J Clin Pharmacol; 2011 May; 71(5):751-7. PubMed ID: 21241353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare professional experiences and attitudes on unlicensed/off-label paediatric prescribing and paediatric clinical trials.
    Mukattash T; Hawwa AF; Trew K; McElnay JC
    Eur J Clin Pharmacol; 2011 May; 67(5):449-61. PubMed ID: 21243345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unlicensed and off-label use of medicines in children admitted to the intensive care units of a hospital in Malaysia.
    Lee JL; Redzuan AM; Shah NM
    Int J Clin Pharm; 2013 Dec; 35(6):1025-9. PubMed ID: 24022725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of off-label and unlicensed paediatric prescribing in a hospital in Indonesia during the period Aug.-Oct. 2014.
    Tukayo BLA; Sunderland B; Parsons R; Czarniak P
    PLoS One; 2020; 15(1):e0227687. PubMed ID: 31935254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extent and nature of unlicensed and off-label medicine use in hospitalised children in Palestine.
    Khdour MR; Hallak HO; Alayasa KS; AlShahed QN; Hawwa AF; McElnay JC
    Int J Clin Pharm; 2011 Aug; 33(4):650-5. PubMed ID: 21567279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug reactions in paediatric surgery: prospective study on frequency and risk related factors.
    Pérez-Ingidua C; Rivas-Paterna AB; González-Perrino C; Aleo-Luján E; Ascaso-Del-Rio A; Laredo-Velasco L; Portolés-Pérez A; Vargas-Castrillón E
    BMC Pediatr; 2024 May; 24(1):344. PubMed ID: 38760745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between adverse drug reactions and unlicensed/off-label drug use in hospitalized children (EREMI): A study protocol.
    Nguyen KA; Mimouni Y; Jaberi E; Paret N; Boussaha I; Vial T; Jacqz-Aigrain E; Alberti C; Guittard L; Remontet L; Roche L; Bossard N; Kassai B
    Therapie; 2021; 76(6):675-685. PubMed ID: 33593598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-label and unlicensed utilization of drugs in a Brazilian pediatric hospital.
    Pereira Gomes V; Melo da Silva K; Oliveira Chagas S; dos Santos Magalhães IR
    Farm Hosp; 2015 May; 39(3):176-80. PubMed ID: 26005894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Off-label and Unlicensed Medicines in Children.
    Lee JH; Byon HJ; Choi S; Jang YE; Kim EH; Kim JT; Kim HS
    J Korean Med Sci; 2018 Sep; 33(37):e227. PubMed ID: 30190655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Off-label prescribing in pediatric outpatients.
    Palmaro A; Bissuel R; Renaud N; Durrieu G; Escourrou B; Oustric S; Montastruc JL; Lapeyre-Mestre M
    Pediatrics; 2015 Jan; 135(1):49-58. PubMed ID: 25511119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands.
    Dittrich ATM; Draaisma JMT; van Puijenbroek EP; Loo DMWMT
    Paediatr Drugs; 2020 Aug; 22(4):425-432. PubMed ID: 32557243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unlicensed and off-label use of medicines at a neonatology clinic in Italy.
    Dell'Aera M; Gasbarro AR; Padovano M; Laforgia N; Capodiferro D; Solarino B; Quaranta R; Dell'Erba AS
    Pharm World Sci; 2007 Aug; 29(4):361-7. PubMed ID: 17351821
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.